Semaglutide Injection Dosing Schedule for Weight Loss

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has transformed weight management by targeting appetite regulation through GLP-1 receptor activation, with patients typically receiving weekly injections across a 16-week titration phase. Understanding the frequency and structure of your dosing schedule helps you prepare for treatment and track expected progress. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies, allowing you to follow clinical dosing protocols without the insurance barriers of brand-name alternatives.

Weekly Injection Frequency and Standard Dosing Protocol

Semaglutide injections for weight loss follow a once-weekly administration schedule, meaning you take one dose every seven days on the same day each week. The standard clinical protocol begins with a 0.25 mg starting dose and increases gradually over 16 weeks to a maintenance dose of 2.4 mg weekly. This stepwise approach allows your body to adapt to the medication while reducing nausea and gastrointestinal side effects that can occur with faster dose escalation.

The weekly rhythm creates a predictable treatment structure that most patients find manageable compared to daily medications. You inject the medication subcutaneously—under the skin—using a small pen device, typically in the abdomen, thigh, or upper arm. Rotating injection sites helps prevent lipohypertrophy, a localized thickening of fat tissue that can develop with repeated injections in the same location.

The 16-Week Titration Phase: What to Expect Monthly

During the first month, your dose remains at 0.25 mg weekly as your body adjusts to the medication's mechanism of action. Week five introduces a 0.5 mg weekly dose, then 1 mg at week nine, and 1.7 mg at week thirteen, with the full 2.4 mg maintenance dose typically reached by week sixteen. Each dose increase happens gradually to allow appetite suppression and metabolic changes to develop steadily, reducing the intensity of adaptation symptoms.

Clinical trials show that weight loss accelerates as doses increase, with maximum benefit typically occurring after sustained use at the 2.4 mg maintenance dose. Many patients experience appetite reduction within days of each dose increase, allowing them to naturally consume fewer calories without constant willpower or restriction. The four-week intervals between dose escalations provide clear measurement points to assess tolerance and adjust your treatment plan if needed.

Maintenance Dosing and Long-Term Weekly Schedules

After reaching the 2.4 mg weekly maintenance dose, you continue with one injection every seven days indefinitely as long as treatment remains effective and tolerable. Some patients plateau in weight loss after 6 to 12 months and may transition to a holding pattern at their current dose, while others benefit from continued use at the 2.4 mg level. Discontinuing semaglutide gradually restores appetite appetite signaling, so weight regain often occurs if treatment stops without lifestyle reinforcement.

PlexusDx supports sustained maintenance therapy through flat-rate monthly pricing that protects you from cost increases as your dose stabilizes. Your dose may need to go up during the titration phase, but your price won't change—you maintain the same $149/mo investment regardless of whether you're at 0.25 mg or 2.4 mg. This predictable cost structure makes long-term weight management planning realistic and financially sustainable.

Personalizing Your Semaglutide Schedule with Genetic Insights

Not every patient responds identically to semaglutide because genetic variation in GLP-1 receptor sensitivity and appetite-regulating pathways influences medication effectiveness. PlexusDx Precision Peptide Genetic Test maps your GLP1R rs6923761 variant and 48 additional peptide-pathway markers across 14 biological systems to predict how your body will respond to semaglutide. This genetic roadmap helps clinicians optimize your starting dose, titration speed, and maintenance strategy based on your unique peptide biology rather than a one-size-fits-all protocol.

Patients carrying specific GLP1R variants may experience faster appetite suppression at lower doses, while others benefit from accelerated titration or extended plateau phases before dose increases. The test also examines GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 variants that influence hunger signaling, metabolic rate, and fat storage patterns. Adding the Precision Peptide Genetic Test ($99 after your first month of treatment) transforms your semaglutide therapy from standard dosing into precision treatment personalized to your genetic predispositions.

Flexibility and Access: Adjusting Your Dosing Without Insurance Barriers

Traditional semaglutide through insurance-covered channels often requires prior authorization delays and formulary restrictions that interrupt consistent dosing schedules. PlexusDx compounded semaglutide from licensed 503A pharmacies eliminates insurance bureaucracy, allowing you to start, adjust, and maintain your weekly injection schedule immediately without prior approval letters or coverage denials. You receive the same clinical dosing protocol as brand-name options but with the accessibility of direct pharmacy delivery to all 50 states.

Your monthly investment at PlexusDx starts at $149/mo and covers your full titration phase and long-term maintenance—no additional per-dose charges, no membership fees, and HSA/FSA eligibility for tax-advantaged savings. If your clinical situation changes or you need to modify your dosing frequency or timing, PlexusDx works directly with you to adjust your prescription without insurance intermediaries. This direct-to-patient model ensures your weekly injection schedule remains consistent and uninterrupted from start through sustained weight loss.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How often do I actually inject semaglutide for weight loss treatment?

You inject semaglutide once every seven days, on the same day each week, throughout your entire treatment journey. The standard protocol spans 16 weeks for dose titration, then continues at the 2.4 mg maintenance dose weekly for as long as treatment remains effective.

Why does semaglutide dosing increase gradually over 16 weeks instead of starting at full dose?

Gradual dose escalation allows your body to adapt to GLP-1 receptor activation, reducing nausea and gastrointestinal side effects while maximizing appetite suppression benefits. Clinical evidence shows that stepwise titration from 0.25 mg to 2.4 mg produces better tolerability and sustained weight loss than rapid dose jumping.

Does PlexusDx charge more as my semaglutide dose increases during titration?

No. PlexusDx pricing remains flat at $149/mo regardless of whether you're starting at 0.25 mg or maintaining at 2.4 mg—your dose may go up, but your price won't. This transparent pricing covers your entire titration phase and ongoing maintenance therapy without hidden per-dose increases or surprise charges.

What happens if I miss a weekly semaglutide injection?

Missing one injection delays your effect for that week, but resuming your regular schedule the following week restores your dosing rhythm without needing to catch up or double-dose.

Can the Precision Peptide Genetic Test help optimize my semaglutide dosing schedule?

Yes. The PlexusDx Precision Peptide Genetic Test examines your GLP1R rs6923761 variant and 48 other peptide-pathway markers to predict your individual response to semaglutide, potentially revealing whether you'll benefit from faster titration, extended plateaus, or personalized maintenance dosing.

How Often Do People Take Ozempic for Weight Loss? Exploring the Dosing Regimen and Its Implications